The influence of hemodialysis on intracranial pressure waveform in patients with chronic kidney disease: an observational study

Autores

Palavras-chave:

Intracranial pressure, Kidney diseases, Renal dialysis, Glomerular filtration rate, Intracranial hypertension, Nervous system diseases, Neurological disorders, Intracranial compliance, Intracranial pressure waveform

Resumo

BACKGROUND: Among the complications related to chronic kidney disease (CKD), those of a neurological nature stand out, and for a better quality of life for patients, the diagnosis and treatment of these complications is fundamental.
OBJECTIVES: This study aimed to assess the effect of hemodialysis on intracranial pressure waveform (ICPw) in patients with chronic kidney disease undergoing hemodialysis and those who are not yet undergoing substitutive therapy.
DESIGN AND SETTING: An observational study was conducted in two stages at a kidney replacement therapy center in Brazil. The first was a longitudinal study and the second was a cross-sectional study.
METHODS: Forty-two patients on hemodialysis were included in the first stage of the study. In the second stage, 226 participants were included. Of these, 186 were individuals with chronic kidney disease (who were not undergoing substitutive therapy), and 40 did not have the disease (control group). The participants’ intracranial compliance was assessed using the non-invasive Brain4care method, and the results were compared between the groups.
RESULTS: There was a significant difference between the hemodialysis and non-hemodialysis groups, with the former having better ICPw conditions.
CONCLUSIONS: Hemodialysis influenced the improvement in ICPw, probably due to the decrease in the patients’ extra-and intracellular volumes. Furthermore, ICPw monitoring can be a new parameter to consider when defining the moment to start substitutive therapy.

Downloads

Não há dados estatísticos.

Biografia do Autor

Mariana Schechtel Koch, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brasil

PhD Candidate, Biologist. Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa (PR), Brazil.

Bianca Drewnowski, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brasil

PhD Candidate. Pharmacist. Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa (PR), Brazil.

Cristiane Rickli, Centro Universitário Integrado, Campo Mourão, Paraná, Brazil

PhD. Biomedic, Professor, Centro Universitário Integrado, Campo Mourão (PR), Brazil.

Fábio André dos Santos, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brasil

PhD. Dentist, Associate Professor, Biological and Health Sciences Division, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa (PR), Brazil.

Gilberto Baroni, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brasil

PhD. Physician, Adjunct Professor, Biological and Health Sciences Division, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa (PR), Brazil.

José Carlos Rebuglio Vellosa, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brasil

PhD. Pharmacist, Associate Professor, Biological and Health Sciences Division, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa (PR), Brazil.

Referências

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7-11. PMID: 35529086; https://doi. org/10.1016/j.kisu.2021.11.003.

Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of hemodialysis outcomes. Nat Rev Nephrol. 2022;18(6):378-95. PMID: 35194215; https:// doi.org/10.1038/s41581-022-00542-7.

Levey AS, Eckardt KU, Tsucamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-100. PMID: 15882252; https://doi.org/10.1111/j.1523-1755.2005.00365.x.

Zwang N, Nigwekar S, Steele D. Hemodialysis complications. In: Magee C, Tucker J, Singh A, editors. Core concepts in dialysis and continuous therapies. Boston: Springer; 2016. p. 39-51.

Rizzo MA, Frediani F, Granata A, et al. Neurological complications of hemodialysis: state of the art. J Nephrol. 2012;25(2):170-82. PMID: 22241633; https://doi.org/10.5301/jn.5000087.

Moraes FM, Rocha E, Barros FCD, et al. Waveform morphology as a surrogate for ICP monitoring: a comparison between an invasive and a noninvasive method. Neurocrit Care. 2022;37(1):219-27. PMID: 35332426; https://doi.org/10.1007/s12028-022-01477-4.

Rickli C, Kalva DC, Frigieri GH, et al. Relationship between dialysis quality and brain compliance in patients with end-stage renal disease (ESRD): a cross-sectional study. São Paulo Med J. 2022;140(3):398-405. PMID: 35507989; https://doi.org/10.1590/1516-3180.2021.0117.r1.14092021.

Vanholder R, Glorieux G, Eloot S. Once upon a time in dialysis: the last days of Kt/V? Kidney Int. 2015;88(3):460-5. PMID: 26061543; https:// doi.org/10.1038/ki.2015.155.

Rickli C, Cosmoski LD, Santos FA, et al. Use of non-invasive intracranial pressure pulse waveform to monitor patients with end-stage renal disease (ESRD). PLoS One. 2021;16(7):e0240570. PMID: 34292964; https:// doi.org/10.1371/journal.pone.0240570.

Brasil. Diretrizes clínicas para o cuidado ao paciente com doença renal crônica – DRC no sistema único de saúde. 1st ed. Brasília: Ministério da Saúde: 2014. Available from: https://ares.unasus.gov.br/acervo/handle/ ARES/1842. Accessed in 2023 (Oct. 30).

STROBE Statement. Strengthening the reporting of observational studies in epidemiology. What is strobe? Available from: http://www. strobe-statement.org/. Accessed in 2022 (Nov. 12).

Cabella B, Vilela GHF, Mascarenhas S, et al. Validation of a new noninvasive intracranial pressure monitoring method by direct comparison with an invasive technique. Acta Neurochir Suppl. 2016;122:93-6. PMID: 27165884; https://doi.org/10.1007/978-3-319-22533-3_18.

Ballestero MFM, Frigieri G, Cabella BCT, Oliveira SM, Oliveira RS. Prediction of intracranial hypertension through noninvasive intracranial pressure waveform analysis in pediatric hydrocephalus. Childs Nerv Syst. 2017;33(9):1517-24. PMID: 28623520; https://doi.org/10.1007/ s00381-017-3475-1.

Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int. 2018;22(2):150-60. PMID: 28799704; https://doi.org/10.1111/hdi.12587.

Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Rev Clin Pharmacol. 2019;12(1):61-90. PMID: 30501441; https:// doi.org/10.1080/17512433.2019.1555468.

Varela AM, Pecoits Filho RFS. Interações entre a doença cardiovascular e a doença renal crônica. J Bras Nefrol. 2006;28(2 suppl. 1):22-8. Available from: https://bjnephrology.org/wp-content/uploads/2019/11/jbn_ v28n3s2a07.pdf. Accessed in 2023 (Oct. 5).

Carter JV, Pan J, Rai SN, Galandiuk S. ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. Surgery.

;159(6):1638-45. PMID: 26962006; https://doi.org/10.1016/j. surg.2015.12.029.

Lakshman SG, Ravikumar P, Kar G, et al. A comparative study of neurological complications in chronic kidney disease with special reference to its stages and haemodialysis status. J Clin Diagn Res. 2016;10(12):OC01-4. PMID: 28208901; https://doi.org/10.7860/jcdr/2016/22815.8947.

Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis. 2016;5:2048004016677687. PMID: 27867500; https://doi.org/10.1177/2048004016677687.

InformedHealth.org [Internet]. Chronic kidney disease: When is the best time to start dialysis? Cologne: Institute for quality and efficiency in health care (IQWiG); 2018. Available from: https://www.ncbi.nlm.nih. gov/books/NBK492982/. Accessed 2023 (Jan. 6).

Petersen LG, Ogoh S. Gravity, intracranial pressure, and cerebral autoregulation. Physiol Rep. 2019;7(6):e14039. PMID: 30912269; https:// doi.org/10.14814/phy2.14039.

Armstead WM. Cerebral blood flow autoregulation and dysautoregulation. Anesthesiol Clin. 2016;34(3):465-77. PMID: 27521192; https://doi.org/10.1016/j.anclin.2016.04.002.

Onodera H, Oshio K, Uchida M, Tanaka Y, Hashimoto T. Analysis of intracranial pressure pulse waveform and brain capillary morphology in type 2 diabetes mellitus rats. Brain Res. 2012;1460:73-7. PMID: 22583857; https://doi.org/10.1016/j.brainres.2012.03.061.

Szmygel Ł, Kosiak W, Zorena K, Myśliwiec M. Optic nerve and cerebral edema in the course of diabetic ketoacidosis. Curr Neuropharmacol. 2016;14(8):784-91. PMID: 26915420; https://doi.org/10.2174/157015 9x14666160225155151.

Subramaniam S, Fletcher WA. Obesity and weight loss in idiopathic intracranial hypertension: a narrative review. J Neuroophthalmol. 2017;37(2):197-205. PMID: 27636748; https://doi.org/10.1097/wno.0000000000000448.

Hannerz J, Ericson K. The relationship between idiopathic intracranial hypertension and obesity. Headache. 2009;49(2):178-84. PMID: 19222591; https://doi.org/10.1111/j.1526-4610.2008.01240.x.

Thurtell MJ. Idiopathic intracranial hypertension. Continuum. 2019;25(5):1289-309. PMID: 31584538; https://doi.org/10.1212/ con.0000000000000770.

Mollan SP, Ali F, Hassan-Smith G, et al. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982-92. PMID: 26888960; https://doi.org/10.1136/jnnp-2015-311302.

Letra L, Sena C. Cerebrovascular disease: consequences of obesityinduced endothelial dysfunction. Adv Neurobiol. 2017;19:163-89. PMID: 28933065; https://doi.org/10.1007/978-3-319-63260-5_7.

Downloads

Publicado

2025-03-27

Como Citar

1.
Koch MS, Drewnowski B, Rickli C, Santos FA dos, Baroni G, Vellosa JCR. The influence of hemodialysis on intracranial pressure waveform in patients with chronic kidney disease: an observational study. Sao Paulo Med J [Internet]. 27º de março de 2025 [citado 15º de outubro de 2025];142(3):1-7. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/3024

Edição

Seção

Artigo Original